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Myocardial Infarction
and Stroke
Not All PFOs Pose a Stroke Risk
Sastry and colleagues sought to study the relationship between venous-to-arterialshunts and arterial embolic events. A total of 100 patients age 16 to 39 years who
have had either a myocardial infarction (MI) or an ischemic stroke were compared to
100 controls. All subjects were evaluated for venous-to-arterial shunts with a transcra-
nial Doppler protocol that detects microbubbles injected intravenously. Subjects were
classified as no shunt, significant shunt, or major shunt based on the number of
microbubbles that were detected in the arteries. There was no association betweenMI
and shunt; only major shunts were associated with stroke which had an odds-ratio of
almost 3. This study suggests that small venous-to-arterial shunts pose little risk for
stroke or MI. See page 686. See figure.
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Invasive Cardiology
Meta-Analysis Suggests Isosmolar is Superior to Low-Osmolar Contrast
Previous studies have related the osmolarity of the angiographic contrast with therisk of contrast induced nephropathy (CIN), but the benefit afforded from
isosmolar contrast media (IOCM, 290mOsm/kg) compared to low-osmolar contrast
media (LOCM, 600 to 800mOsm/kg) has not been definitively proven.McCullough
and colleagues pooled data from almost 3000 patients who had been randomized to
either IOCMorLOCMfor various intra-arterial procedures from16 trials. IOCMuse
was associated with significantly smaller increases in postprocedure serum creatinine
levels (0.06 mg/dl vs. 0.10 mg/dl). The difference was wider for higher risk patients
such as those with baseline renal insufficiency or diabetes. CIN, defined strictly as an
increase of serum creatinine1 mg/dl, was approximately 10 times less with IOCM
versus LOCM. This meta-analysis indicates that the supraphysiologic osmolarity of
LOCM does induce some renal damage which can be reduced with isosmolar
products. See page 698. See figure.
Page 712
Lipids and
Cardiovascular Disease
Reduced Cholesterol Absorption Associated With Improved Prognosis in
Elderly Patients
Researchers in Finland studied almost 400 elderly subjects with previous athero-sclerotic events, to determine the prognostic value of measuring cholesterol
absorption. Cholesterol absorption was assessed with the serum cholestanol to choles-
terol concentration ratio; a lower level reflects decreased cholesterol absorption. After
4 years of follow-up, the baseline serum total and low-density lipoprotein-cholesterol
levels did not predict future events, but risk did increase with increasing levels choles-
terol absorption. Understanding the relationship between cholesterol absorption, cho-
lesterol synthesis, and cardiovascular risk will improve our ability to identify patients at
risk and find new targets for intervention. See page 708. See figure.
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Heart Rhythm Disorders
Improved Quality of Life With Maintenance of Sinus Rhythm
While it appears that there is no mortality benefit to using anti-arrhythmicmedications to maintain sinus rhythm (SR) in patients with atrial fibrillation
(AF), there is ongoing debate regarding its effects on symptoms. Singh and colleagues
report on data collected from the SAFE-T trial that assigned patients to sotalol,
amiodarone, or placebo.Rather than reporting the effect of anyof thesemedications on
quality of life (QOL), subjects were stratified by their rhythm at specified follow-up
dates. Sinus rhythmwas associated with improvements inmost measures of QOL and
with improved treadmill duration. The authors conclude that: “In patients with
persistentAF, restoration andmaintenance of SRwas associatedwith improvements in
QOL measures and exercise performance.” See page 721. See figure.
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Heart Rhythm Disorders
AV Node Ablation May Be Necessary for CRT Benefit in Patients With AF
While cardiac resynchronization therapy (CRT) improves left ventricular (LV)function in patients with reduced ejection fraction and prolonged QRS, the
utility of CRT in patients with atrial fibrillation (AF) is not clear. Gasparini and
colleagues developed a protocol whereby the frequency of biventricular pacing was
assessed in patients with AF and CRT. If, despite adequate rate-controlling medica-
tions the percentage of paced beats was85%, patients were referred for atrioventric-
ular node ablation. Over 4 years of follow-up, patients who had been ablated showed
similar improvements in LV size and functional capacity as patients with sinus rhythm.
Patients who remained in AFwithout undergoing ablation showed no improvements.
This study suggests that patients with AF and other standard criteria for CRT should
undergo AV nodal ablation at the time of CRT implantation. See page 734. See
figure.
Cardiac Imaging
Utility of MDCT to Assess for CAD in Post-Cardiac Transplant Patients
Most institutions that performcardiac transplants specify that all subjects undergoannual coronary angiography to assess for asymptomatic coronary atheroscle-
rosis which is the leading cause of death in patients who survive more than one year.
Whilemulti-detector computed tomography (MDCT)has shown acceptable accuracy
in many patient groups, the cardiac denervation associated with transplantation often
leads to mild tachycardias that are not responsive to beta-blockade and may interfere
with the spatial resolution of MDCT. Sigurdsson and colleagues performed MDCT
andcoronary angiography in54 transplant recipients.The averageheart rate during the
scan was 90 beats/min, yet 95% of the coronary segments were deemed analyzable by
MDCT.MDCT correctly identified 15 of the 16 (94%) transplant patients classified
by quantitative coronary angiography as having occlusive coronary artery disease and
29 of the 37 patients without significant stenosis (78%). This study suggests that
MDCT may have a role in replacing annual coronary angiography in post-cardiac
transplant patients. See page 772.
